News
11h
Zacks Investment Research on MSNAre You a Value Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
1d
Zacks Investment Research on MSNAre You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
A pivotal moment in the KRAS inhibitor market occurred in 2021 with the approval of Lumakras for the treatment of non-small cell lung cancer (NSCLC), representing a significant breakthrough for ...
Eric Groen will serve as legal chief, compliance chief and head of business development for Genelux Corp., which is led by a former Amgen colleague.
Amgen Inc. filed a lawsuit in Massachusetts federal court accusing Biocon Ltd. units of infringing nearly three dozen patents with its proposed biosimilars of the bone drugs Prolia and Xgeva.
Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with chemotherapy, according to interim data from a late-stage study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results